Willow Biosciences Inc. 3D7.F Stock
0.06 EUR
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
7.74M EUR
LOW - HIGH [24H]
0.06
-
0.06 EUR
VOLUME [24H]
4.87K EUR
{{ volume }}
P/E Ratio
0
Earnings per share
-0.07 EUR
Willow Biosciences Inc. Price Chart
Willow Biosciences Inc. 3D7.F Financial and Trading Overview
| Willow Biosciences Inc. stock price | 0.06 EUR |
| Previous Close | 0.08 EUR |
| Open | 0.08 EUR |
| Bid | 0.08 EUR x N/A |
| Ask | 0.1 EUR x N/A |
| Day's Range | 0.08 - 0.08 EUR |
| 52 Week Range | 0.04 - 0.14 EUR |
| Volume | 400 EUR |
| Avg. Volume | 7 EUR |
| Market Cap | 12.04M EUR |
| Beta (5Y Monthly) | 1.100545 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.07 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2 EUR |
3D7.F Valuation Measures
| Enterprise Value | -303232 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.992642 |
| Price/Book (mrq) | 0.8789474 |
| Enterprise Value/Revenue | -0.277 |
| Enterprise Value/EBITDA | 0.018 |
Trading Information
Willow Biosciences Inc. Stock Price History
| Beta (5Y Monthly) | 1.100545 |
| 52-Week Change | -30.80% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.14 EUR |
| 52 Week Low | 0.04 EUR |
| 50-Day Moving Average | 0.07 EUR |
| 200-Day Moving Average | 0.07 EUR |
3D7.F Share Statistics
| Avg. Volume (3 month) | 7 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 124.22M |
| Float | 88.45M |
| Short Ratio | N/A |
| % Held by Insiders | 27.89% |
| % Held by Institutions | 0.12% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1680.36% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -52.47% |
| Return on Equity (ttm) | -85.26% |
Income Statement
| Revenue (ttm) | 1.1M EUR |
| Revenue Per Share (ttm) | 0.009 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 821K EUR |
| EBITDA | -16968000 EUR |
| Net Income Avi to Common (ttm) | -16615000 EUR |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.81M EUR |
| Total Cash Per Share (mrq) | 0.09 EUR |
| Total Debt (mrq) | 507K EUR |
| Total Debt/Equity (mrq) | 4.31 EUR |
| Current Ratio (mrq) | 6.708 |
| Book Value Per Share (mrq) | 0.095 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14624000 EUR |
| Levered Free Cash Flow (ttm) | -8404250 EUR |
Profile of Willow Biosciences Inc.
| Country | Germany |
| State | AB |
| City | Calgary |
| Address | 202, 1201-5th Street SW |
| ZIP | T2R 0Y6 |
| Phone | 403 910 5140 |
| Website | https://www.willowbio.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 32 |
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. Willow Biosciences Inc. is headquartered in Calgary, Canada.
Q&A For Willow Biosciences Inc. Stock
What is a current 3D7.F stock price?
Willow Biosciences Inc. 3D7.F stock price today per share is 0.06 EUR.
How to purchase Willow Biosciences Inc. stock?
You can buy 3D7.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Willow Biosciences Inc.?
The stock symbol or ticker of Willow Biosciences Inc. is 3D7.F.
Which industry does the Willow Biosciences Inc. company belong to?
The Willow Biosciences Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Willow Biosciences Inc. have in circulation?
The max supply of Willow Biosciences Inc. shares is 136.96M.
What is Willow Biosciences Inc. Price to Earnings Ratio (PE Ratio)?
Willow Biosciences Inc. PE Ratio is now.
What was Willow Biosciences Inc. earnings per share over the trailing 12 months (TTM)?
Willow Biosciences Inc. EPS is -0.07 EUR over the trailing 12 months.
Which sector does the Willow Biosciences Inc. company belong to?
The Willow Biosciences Inc. sector is Healthcare.